Se prevé que el mercado de medicamentos para animales de granja crezca de 18.253,09 millones de dólares en 2021 a 28.364,08 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 6,5% de 2021 a 2028.
Los medicamentos desempeñan un papel clave en el mantenimiento de la salud de los animales de granja y la mejora de la condición económica de productores agrícolas. La necesidad de una mayor productividad se ha vuelto cada vez más importante, ya que la población busca productos alimenticios nutritivos y libres de enfermedades. Los compuestos farmacológicamente activos ayudan a prevenir la transmisión de enfermedades de los animales a los humanos. La salud de los animales de granja se ha visto considerablemente afectada por el uso de drogas. Los medicamentos para animales de granja son medicamentos que se utilizan en prácticas sanitarias para el diagnóstico, cura, mitigación, tratamiento o prevención de enfermedades que podrían afectar al ganado. Estos medicamentos se utilizan según requisitos estrictos basados en su esencialidad para mantener el bienestar de los animales de granja. En pocas palabras, los medicamentos para animales de granja son un factor clave que respalda el crecimiento de la industria ganadera en todo el mundo. Factores como el creciente uso de analgésicos en animales de granja, la creciente incidencia de enfermedades e infecciones transmitidas por los alimentos y la creciente demanda de productos farmacéuticos de calidad y la seguridad alimentaria impulsan el crecimiento del mercado de medicamentos para animales de granja. Sin embargo, los efectos secundarios de los medicamentos en los animales y las estrictas normas gubernamentales relacionadas con el uso de medicamentos para animales de granja obstaculizan el crecimiento del mercado.
Perspectivas estratégicas
< br>
regiones lucrativas para el mercado de medicamentos para animales de granja
Perspectivas del mercado
Uso creciente de medicamentos para el tratamiento del dolor en animales de granja refuerza el crecimiento del mercado de medicamentos para animales de granja
El dolor en los animales de granja a menudo se asocia con enfermedades de producción comunes, como cojera y mastitis, y se transmite al animal a través de prácticas de cría de rutina, como la castración y la cola. unión cósmica. El dolor provoca cambios conductuales, autónomos y neuroendocrinos; e induce un estado afectivo negativo, compromete el bienestar animal y perjudica la rentabilidad de la agricultura.
Controlar el dolor es esencial para la salud de todos los animales. En 2018, la Administración de Alimentos y Medicamentos (FDA) aprobó el primer analgésico para su uso en un animal productor de alimentos. La pietín es una causa común de dolor y cojera en ganado de todas las edades y razas. La enfermedad se observa en ganado criado en graneros y torres de alta tensión, así como en ganado en pasto. Banamine Transdermal está aprobado para tratar el dolor asociado con la pietín en el ganado y solo se puede dispensar con receta médica. El Centro de Medicina Veterinaria de la FDA promueve y protege la salud animal garantizando que haya medicamentos seguros y eficaces disponibles para los animales. Trabajar con compañías farmacéuticas para desarrollar y aprobar medicamentos para controlar el dolor en todos los animales, incluidos los animales productores de alimentos, es una parte integral de esta misión.
Existen varias prácticas rutinarias en animales. cría que exige un manejo eficiente del dolor en los animales. Algunos procedimientos de rutina que causan dolor en los animales de granja incluyen la castración, el descornado o el desmoche. y marca. Los fármacos más comunes utilizados para controlar el dolor en animales de granja incluyen fármacos antiinflamatorios no esteroides (AINE), anestésicos locales, agonistas α2 y opioides. El manejo eficiente del dolor en animales productores de alimentos se ha convertido gradualmente en un motivo de preocupación para los consumidores en todo el mundo y, por lo tanto, ha despertado un gran interés por parte de las autoridades reguladoras. En consecuencia, la industria ganadera en todo el mundo está evolucionando con nuevas prácticas y el uso de analgésicos no autorizados teniendo en cuenta el bienestar animal y la rentabilidad. Por lo tanto, esto ha llevado a un aumento significativo de fármacos analgésicos como lidocaína, xilazina, detomidina, medetomidina, ketamina, ácido tolfenámico, buprenefrina, etc. en la práctica general de manejo del dolor en animales de granja.
Los consumidores son cada vez más conscientes y preocupados por el bienestar de los animales criados para consumo humano. Esto ha ejercido presión sobre los proveedores para garantizar que los animales que ingresan a sus sistemas sean tratados humanamente. Se están adoptando medidas para hacer frente a esa demanda. Sólo un medicamento está aprobado en los EE. UU. para controlar el dolor del flemón interdigital (podredumbre del pie) en ganado no lactante. Por lo tanto, el uso de medicamentos para el manejo del dolor en procedimientos electivos, como el descornado y la castración, en ganado vacuno o analgesia en vacas lecheras y cerdos lactantes se considera un uso de medicamento fuera de la etiqueta. Está regulado según la aclaración sobre el uso de la ley de medicamentos veterinarios. El flunixino, el meloxicam y el ketoprofeno son fármacos antiinflamatorios no esteroides con investigaciones que respaldan la analgesia en granjas. Varios productos, como anestésicos locales y regionales, opioides y antiinflamatorios no esteroides (AINE), están disponibles en el mercado para aliviar el dolor en los animales.
Producto Información basada en tipos
Según el tipo de producto, el mercado de medicamentos para animales de granja se segmenta en antiinfecciosos, parasiticidas, antiinflamatorios, anestésicos, analgésicos, hormonas y productos relacionados, entre otros. El segmento de parasiticidas tuvo la mayor participación de mercado en 2021 y se espera que registre la CAGR más alta durante el período de pronóstico.
Mercado de medicamentos para animales de granja, por tipo de producto: 2021 y 2028
Información basada en el tipo de animal
Basado en el tipo de animal, el mercado de medicamentos para animales de granja Se bifurca en animales ganaderos y equinos. El segmento de animales de ganado tuvo la mayor cuota de mercado del 90,77% en 2021 y se espera que mantenga su dominio durante el período de pronóstico.
Ruta de conocimientos basados en la administración< /h3>
Según la vía de administración, el mercado de medicamentos para animales de granja se segmenta en orales, parenterales, tópicos y otros. El segmento oral tuvo la mayor cuota de mercado del 90,77 % en 2021 y se espera que mantenga su dominio durante el período de pronóstico.
Información basada en el canal de distribución
Según el canal de distribución, el mercado de medicamentos para animales de granja se segmenta en hospitales veterinarios, clínicas veterinarias, farmacias y droguerías, entre otros. El segmento de hospitales veterinarios tuvo la mayor participación de mercado en 2021, mientras que se espera que el mercado del segmento de clínicas veterinarias crezca a una tasa compuesta anual del 6,9% durante el período de pronóstico.
Varias empresas que operan en el mercado de medicamentos para animales de granja están adoptando estrategias como lanzamientos de productos, fusiones y adquisiciones, colaboraciones, innovaciones de productos y ampliaciones de carteras de productos para expandir su presencia en todo el mundo, mantener la marca y satisfacer la creciente demanda de los usuarios finales.
Mercado de medicamentos para animales de granja: por tipo de producto
- Antiinfecciosos
- Parasiticidas
- Antiinflamatorios
- Anestésicos
- Analgésicos
- Hormonas y productos relacionados
- Otros
Mercado de medicamentos para animales de granja – ndash; por tipo de animal
- Animal ganado
- Equino
Mercado de medicamentos para animales de granja – ndash; por Vía de Administración
- Oral
- Parenteral
- Tópica
- Otras
Mercado de medicamentos para animales de granja: por Canal de Distribución
- Hospitales Veterinarios
- Clínicas Veterinarias
- Farmacias y Droguerías
- Otros
- Estados Unidos
- Canadá
- México
- Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- China
- India
- Corea del Sur
- Japón
- Australia< /li>
- Resto de Asia Pacífico
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de Medio Oriente y África África
- Brasil
- Argentina
- Resto de Sudamérica y Centroamérica
- PHIBRO ANIMAL HEALTH CORPORATION
- Zoetis Inc.
- Ceva
- Elanco< /li>
- Virbac
- INTAS PHARMACEUTICALS LTD.
- Alembic Pharmaceuticals Limited
- Boehringer Ingelheim International GmbH
- MSD Animal Health < /li>
- Vetoquinol SA
Mercado de medicamentos para animales de granja: por Geografía
• América del Norte
• Europa
• Asia Pacífico (APAC)
• Medio Oriente y Asia África (MEA)
• Sur y Centroamérica (SCAM)
Perfiles de la empresa
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Drugs play a key role in maintaining the health of farm animals and improving the economic condition of farm producers. The need for better productivity has become important more, as the population are looking for nutritious and disease-free food products. The pharmacologically active compounds help prevent the passing of diseases from animals to humans. Farm animal’s health have been considerably shaped by the use of drugs. Farm animal drugs are medicines used for healthcare-based practices for diagnosis, cure, mitigation, treatment, or prevention of diseases that could affect livestock. These medicines are used as per strict requirements based on their essentiality to maintain the well-being of farm animals. Simply said, farm animal drugs are a key factor supporting the growth of the livestock industry across the world.
Key factors that are driving the growth of this market are the growing use of pain management drugs in farm animals, rising incidence of foodborne diseases and infections, and surging demand for quality pharmaceuticals and food security are expected to boost the market growth for the farm animal drugs over the years.
The parasiticides segment dominated the global farm animal drugs market and held the largest revenue share of 26.88% in 2021.
The livestock animals segment dominated the global farm animal drugs market and accounted for the largest revenue share of 90.77% in 2021
The oral segment dominated the global farm animal drugs market and accounted for the largest revenue share of 42.81% in 2021.
The veterinary hospitals segment dominated the global farm animal drugs market and accounted for the largest revenue share of 36.70% in 2021.
The farm animal drugs market majorly consists of the players such PHIBRO ANIMAL HEALTH CORPORATION, Zoetis Inc., Ceva, Elanco, Virbac, INTAS PHARMACEUTICALS LTD., Alembic Pharmaceuticals Limited, Boehringer Ingelheim International GmbH, MSD Animal Health, and Vetoquinol SA among others.
The List of Companies - Farm Animal Drugs Market
- PHIBRO ANIMAL HEALTH CORPORATION
- Zoetis Inc.
- Ceva
- Elanco
- Virbac
- INTAS PHARMACEUTICALS LTD.
- Alembic Pharmaceuticals Limited
- Boehringer Ingelheim International GmbH
- MSD Animal Health
- Vetoquinol SA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Nov 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Nov 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Nov 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)